Sarah H. Lisanby, MD
Lawrence C. Katz Professor and Chair, Department of Psychiatry and Behavioral Sciences
Division Director, Brain Stimulation and Neurophysiology and General Psychiatry
Department / Division
Psychiatry /
Biological Psychiatry
Address
DUMC 3950
Durham, NC 27710
Appointment Telephone
919-681-0603
Office Telephone
919-684-5616
Fax Telephone
919-681-5489
- MD, Duke University School of Medicine, 1991
- Psychiatry and Behavioral Sciences, Duke University Medical Center, 1991-1995
- Affective Disorders (Research), Columbia University (New York), 1995-1998
- Board Certification, American Board of Psychiatry and Neurology
- Board Certification, Added Qualifications in Geriatric Psychiatry
Clinical Interests
Treatment-resistant depression (TRD), and other conditions when conventional treatments fail; brain stimulation, including transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), magnetic seizure therapy (MST), deep-brain stimulation (DBS) and vagus nerve stimulation (VNS); advanced training in the delivery of device-based therapies, including transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), deep brain stimulation (DBS), magnetic seizure therapy (MST), transcranial direct-current stimulation (tDCS)
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Advanced Neuromodulation Systems (St. Jude Medical, Inc.)
- Brainsway
- Bristol-Myers Squibb
- Eli Lilly & Co.
- Johnson & Johnson
- Magstim
- Magventure
- Neosync
- Pfizer Inc.
